Why this research matters
Type 1 studies at Lumos enroll adults, and for some protocols, adolescents, living with T1D. Participation usually means more frequent monitoring, structured lab work and closer clinical attention than routine endocrine care provides, all at no cost.
Is this you?
A study may be worth a conversation if some of this sounds familiar:
Screening is free, confidential and decides nothing by itself. It simply tells you whether a current study fits.
Your path into a study
Common questions
No, study participation runs alongside your existing care, and with your permission the study team coordinates with your treating physicians.
Sometimes it's exactly the right time, several current research directions focus on newly diagnosed patients, where preserving remaining beta-cell function matters most. Screening will tell you honestly.
No. Study-related visits, investigational treatment and study lab work are provided at no cost, and no insurance is needed for any of it.
Not enrolling for type 1 diabetes right now?
Join the research registry and you’ll be contacted first when a matching study opens. Or explore other areas we’re currently studying:
